EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 241 filers reported holding EDITAS MEDICINE INC in Q3 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $0 | – | 24 | 0.0% | 0.00% | – |
| Q4 2022 | $0 | – | 24 | +9.1% | 0.00% | – |
| Q3 2022 | $0 | – | 22 | -4.3% | 0.00% | – |
| Q2 2022 | $0 | – | 23 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 23 | -89.9% | 0.00% | -100.0% |
| Q4 2021 | $6,000 | -70.0% | 227 | -54.2% | 0.00% | -83.3% |
| Q3 2021 | $20,000 | -42.9% | 496 | -19.6% | 0.01% | -50.0% |
| Q2 2021 | $35,000 | +20.7% | 617 | -10.7% | 0.02% | +9.1% |
| Q1 2021 | $29,000 | -31.0% | 691 | +16.5% | 0.02% | -33.3% |
| Q4 2020 | $42,000 | +44.8% | 593 | -42.0% | 0.03% | +37.5% |
| Q3 2020 | $29,000 | +7.4% | 1,022 | +12.1% | 0.02% | +4.3% |
| Q2 2020 | $27,000 | +42.1% | 912 | -3.7% | 0.02% | +15.0% |
| Q1 2020 | $19,000 | -29.6% | 947 | +4.3% | 0.02% | -63.6% |
| Q4 2019 | $27,000 | +28.6% | 908 | -3.7% | 0.06% | +22.2% |
| Q3 2019 | $21,000 | 0.0% | 943 | +11.1% | 0.04% | -11.8% |
| Q2 2019 | $21,000 | +50.0% | 849 | +45.6% | 0.05% | -23.9% |
| Q1 2019 | $14,000 | – | 583 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 1,674,435 | $51,455,000 | 13.05% |
| TRV GP III, LLC | 906,176 | $27,847,000 | 9.75% |
| ARK Investment Management | 1,112,845 | $34,198,000 | 2.72% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,709,400 | $52,530,000 | 2.07% |
| Casdin Capital, LLC | 133,333 | $4,097,000 | 1.00% |
| Global Thematic Partners, LLC | 614,052 | $18,869,000 | 0.62% |
| MORGENS WATERFALL VINTIADIS & CO INC | 20,000 | $615,000 | 0.48% |
| Ghost Tree Capital, LLC | 65,000 | $1,997,000 | 0.47% |
| ACUTA CAPITAL PARTNERS, LLC | 64,000 | $1,967,000 | 0.37% |
| VIKING GLOBAL INVESTORS LP | 1,709,401 | $52,530,000 | 0.32% |